Details for New Drug Application (NDA): 090025
✉ Email this page to a colleague
The generic ingredient in LEVETIRACETAM is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 090025
Tradename: | LEVETIRACETAM |
Applicant: | Lupin |
Ingredient: | levetiracetam |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 090025
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 090025
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVETIRACETAM | levetiracetam | TABLET;ORAL | 090025 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-7979 | 0615-7979-39 | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-7979-39) |
LEVETIRACETAM | levetiracetam | TABLET;ORAL | 090025 | ANDA | A-S Medication Solutions | 50090-6378 | 50090-6378-0 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-6378-0) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1GM | ||||
Approval Date: | Jan 15, 2009 | TE: | AB | RLD: | No |
Complete Access Available with Subscription